EG14891A - A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility - Google Patents

A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility

Info

Publication number
EG14891A
EG14891A EG280/81A EG28081A EG14891A EG 14891 A EG14891 A EG 14891A EG 280/81 A EG280/81 A EG 280/81A EG 28081 A EG28081 A EG 28081A EG 14891 A EG14891 A EG 14891A
Authority
EG
Egypt
Prior art keywords
rifamicyn
imiadozo
derivatives
preparation
new
Prior art date
Application number
EG280/81A
Other languages
English (en)
Inventor
Marchi Egidio
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Application granted granted Critical
Publication of EG14891A publication Critical patent/EG14891A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EG280/81A 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility EG14891A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (1)

Publication Number Publication Date
EG14891A true EG14891A (en) 1985-12-31

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
EG280/81A EG14891A (en) 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility

Country Status (25)

Country Link
US (1) US4341785A (en])
JP (1) JPS5711987A (en])
AR (1) AR226212A1 (en])
AT (1) AT373599B (en])
AU (1) AU537093B2 (en])
BE (1) BE888895A (en])
CA (1) CA1142518A (en])
CH (1) CH648037A5 (en])
DE (1) DE3120460A1 (en])
DK (1) DK157876C (en])
EG (1) EG14891A (en])
ES (1) ES8203388A1 (en])
FI (1) FI69467C (en])
FR (1) FR2482967A1 (en])
GB (1) GB2079270B (en])
GR (1) GR75640B (en])
IE (1) IE51204B1 (en])
IT (1) IT1154655B (en])
LU (1) LU83376A1 (en])
NL (1) NL187022C (en])
NO (1) NO155622C (en])
PH (2) PH17207A (en])
PT (1) PT73064B (en])
SE (1) SE453089B (en])
ZA (1) ZA813430B (en])

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
EP0861660B9 (en) * 1997-02-28 2006-06-28 Kaneka Corporation Curative medicine for disease caused by infection of Helicobacter
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
AU2003276254A1 (en) * 2002-11-05 2004-06-07 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
DK1698630T3 (da) * 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0614758A2 (pt) 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
CN101594885B (zh) 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
PL2054066T3 (pl) 2006-08-02 2015-12-31 Salix Pharmaceuticals Inc Sposoby leczenia popromiennego zapalenia jelit
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
EP2069363B1 (en) * 2006-09-22 2013-03-20 Cipla Ltd. Rifaximin in an amorphous form
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
ES2798253T3 (es) 2007-07-06 2020-12-10 Lupin Ltd Composiciones farmacéuticas de rifaximina
JP5755878B2 (ja) 2007-07-06 2015-07-29 ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミンの薬剤組成物
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
EP2257557A4 (en) * 2008-02-25 2011-06-29 Salix Pharmaceuticals Ltd FORMS OF RIFAXIMINE AND APPLICATIONS THEREOF
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
CN101959412A (zh) 2008-02-26 2011-01-26 萨利克斯药品有限公司 治疗肠病的方法
PL2294012T3 (pl) 2008-05-07 2014-12-31 Salix Pharmaceuticals Inc Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit
WO2010019511A2 (en) 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2010035751A1 (ja) 2008-09-26 2010-04-01 あすか製薬株式会社 機能性消化管障害の予防及び／又は治療剤
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
ES2770308T3 (es) 2008-10-02 2020-07-01 Salix Pharmaceuticals Ltd Procedimientos de tratamiento de encefalopatía hepática
ES2718614T3 (es) 2008-12-10 2019-07-03 Cipla Ltd Complejos de rifaximina
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
NZ596851A (en) 2009-06-02 2013-10-25 Salix Pharmaceuticals Ltd Methods of treating hepatic encephalopathy
BR112012005627A2 (pt) 2009-09-13 2017-02-21 Salix Pharmaceuticals Ltd "uso de rifaximina para preparação de um medicamento para tratar síndrome do intestino irritável (ibs)"
NZ599944A (en) 2009-10-27 2015-10-30 Lupin Ltd Solid dispersion of rifaximin
EP2503989A2 (en) 2009-11-23 2012-10-03 Cipla Limited Topical foam composition
EP2401282B2 (en) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
EP3650022A1 (en) 2010-02-18 2020-05-13 Salix Pharmaceuticals, Ltd. Methods for treating rifampin resistant clostridium difficilis infections
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
JP6092629B2 (ja) 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
PT2593463T (pt) 2010-07-12 2020-09-17 Salix Pharmaceuticals Ltd Formulações de rifaximina e usos das mesmas
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
CA2825964A1 (en) 2011-02-11 2012-08-16 Salix Pharmaceuticals, Ltd. Forms of rifaximin and uses thereof
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
PL2773205T3 (pl) 2011-11-02 2024-09-02 Salix Pharmaceuticals, Inc. Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
JP2015509105A (ja) * 2012-01-25 2015-03-26 サリックス ファーマスーティカルズ，リミテッド リファキシミン誘導体及びその使用
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US9849090B2 (en) 2012-12-12 2017-12-26 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of rifaximin
EP2971062A2 (en) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Method for diagnosing vaginal infections
EA201591267A1 (ru) 2013-03-15 2016-03-31 Альфа Вассерманн С.П.А. Рифаксимин для применения в лечении вагинальных инфекций
AU2014252219B2 (en) 2013-04-12 2018-11-22 Alfasigma S.P.A. NSAID administration and related compositions, methods and systems.
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
EP2927235B1 (en) 2014-03-31 2017-02-08 Euticals S.P.A. Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
WO2015159275A2 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
WO2015171493A1 (en) 2014-05-04 2015-11-12 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
HUE044748T2 (hu) 2014-05-12 2019-11-28 Alfasigma Spa Rifaximin új szolvatált kristályos formája, annak elõállítása, azokat tartalmazó kompozíciók, és alkalmazásuk
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
CN110072525B (zh) 2016-09-30 2022-12-02 萨利克斯药品公司 利福昔明的固态分散形式
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (en]) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
FI811565L (fi) 1981-11-23
PT73064A (en) 1981-06-01
GR75640B (en]) 1984-08-02
NO155622C (no) 1987-04-29
JPS6123192B2 (en]) 1986-06-04
AT373599B (de) 1984-02-10
PH17207A (en) 1984-06-19
AU7065581A (en) 1981-11-26
LU83376A1 (fr) 1981-09-11
FR2482967B1 (en]) 1985-03-29
FR2482967A1 (fr) 1981-11-27
PH18704A (en) 1985-09-05
ATA222781A (de) 1983-06-15
FI69467B (fi) 1985-10-31
IT8003429A0 (it) 1980-05-22
ES502906A0 (es) 1982-04-01
AR226212A1 (es) 1982-06-15
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
DK157876C (da) 1990-07-30
DE3120460C2 (en]) 1990-12-13
NO811731L (no) 1981-11-23
IT1154655B (it) 1987-01-21
FI69467C (fi) 1986-02-10
DK157876B (da) 1990-02-26
NL187022B (nl) 1990-12-03
GB2079270B (en) 1984-01-18
US4341785A (en) 1982-07-27
CA1142518A (en) 1983-03-08
IE51204B1 (en) 1986-10-29
ES8203388A1 (es) 1982-04-01
GB2079270A (en) 1982-01-20
BE888895A (fr) 1981-09-16
ZA813430B (en) 1982-06-30
SE453089B (sv) 1988-01-11
NL187022C (nl) 1991-05-01
DK224781A (da) 1981-11-23
JPS5711987A (en) 1982-01-21
NL8102290A (nl) 1981-12-16
NO155622B (no) 1987-01-19
CH648037A5 (de) 1985-02-28
IE811139L (en) 1981-11-22
AU537093B2 (en) 1984-06-07
DE3120460A1 (de) 1982-03-11

Similar Documents

Publication Publication Date Title
EG14891A (en) A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility
DE3161172D1 (en) A process for the preparation of ethanol
YU122783A (en) Process for preparation of sin-isomeres
YU142983A (en) Process for making derivatives of 1-sulpho-2-oxoazetidyne
PL248815A1 (en) Process for preparing novel beta-lactamic derivatives of antibacterial activity
DE3173511D1 (en) Cephalosporin derivatives, a process for their preparation and compositions containing them
PT67884B (en) Process for the preparation of a n-acethyl-dehydro-thienamycin antibiotic
ZA82552B (en) A process for the preparation of carbapenem derivatives
GB2067991B (en) Process for the preparation of a furan derivative
DE3268639D1 (en) Process for the preparation of a furan derivative
YU156883A (en) Process for preparing substituted derivatives of phenoxyamino-propanol
DE3170346D1 (en) Process for the preparation of a furan derivative
DE3262080D1 (en) Process for the preparation of a furan derivative
ZA803952B (en) A process for the preparation of 15-hydroxyimino-e-homoeburnane derivatives
PT72487B (en) Process for the preparation of indane derivatives having phar- maceutical properties
MW880A1 (en) Process for preparation of b-lactam compounds
PT72320A (en) Process for preparation of a furan derivative
DE3163891D1 (en) Process for the preparation of vinylphosphoric-acid derivatives
PT73894A (en) Process for the preparation of a fungicidal composition containing pirazole-substituted oximino-cyano-acetamide derivatives
IL59761A0 (en) A process for the preparation of substituted 2-aminopyrazines
RO83972A (ro) Procedeu de preparare a derivatilor de oxazafosfarine
PL243473A1 (en) Process for preparing novel derivatives of 11-aza-10-desoxy-10-dihydroerythromycin a
PL237694A1 (en) Process for preparing novel derivatives of benzothiazinecarboxamide
DE3162428D1 (en) Process for the preparation of dihydrocinnamaldehyde derivatives
DE3176888D1 (en) Process for the preparation of a 6-alkyl-valerolactone